BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8438459)

  • 1. Rapamycin effects on immunologic reconstitution.
    Vogelsang GB; Hess AD
    Transplant Proc; 1993 Feb; 25(1 Pt 1):727-8. PubMed ID: 8438459
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential effects of cyclosporin-A and rapamycin on in vivo thymocyte maturation.
    Homma M; Damoiseaux JG; van Breda Vriesman PJ
    Transplant Proc; 1997 May; 29(3):1743-4. PubMed ID: 9142256
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Vallera DA
    J Immunol; 1998 Jun; 160(11):5355-65. PubMed ID: 9605135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Route of administration determines the efficacy of rapamycin but not the mechanisms of tolerance induced by it in rats.
    Lin Y; Rutgeerts O; Waer M
    Transplant Proc; 1996 Dec; 28(6):3057. PubMed ID: 8962185
    [No Abstract]   [Full Text] [Related]  

  • 5. Modes of action of FK506, cyclosporin A, and rapamycin.
    Morris R
    Transplant Proc; 1994 Dec; 26(6):3272-5. PubMed ID: 7527964
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporine preferentially inhibits clonal deletion of CD8-positive T cells with an MHC class II restricted autoreactive T-cell receptor.
    Severino ME; Laulis MK; Horwitz LR; Hess AD
    Transplant Proc; 1993 Feb; 25(1 Pt 1):520-3. PubMed ID: 8438399
    [No Abstract]   [Full Text] [Related]  

  • 7. Synergistic activity of the triple combination: cyclosporine, rapamycin, and brequinar.
    Stepkowski SM; Kahan BD
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):29-31. PubMed ID: 8516939
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of rapamycin after syngeneic bone marrow transplantation in irradiated mice.
    Quesniaux V; Gibbons H; Maurer C; Stirnimann R; Wehrli S
    Transplant Proc; 1996 Dec; 28(6):3065-71. PubMed ID: 8962188
    [No Abstract]   [Full Text] [Related]  

  • 9. The antimicrobial activities of cyclosporine, FK506, and rapamycin.
    High KP
    Transplantation; 1994 Jun; 57(12):1689-700. PubMed ID: 7517076
    [No Abstract]   [Full Text] [Related]  

  • 10. Endocardial mononuclear cell infiltrates (Quilty effect) in heterotopic cardiac allografts in rapamycin-treated rats.
    Mohacsi PJ; Joshi A; Wang J; Morris RE; Billingham ME
    Transplant Proc; 1994 Dec; 26(6):3255-9. PubMed ID: 7998133
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunological mechanisms governing tolerance to self-major histocompatibility complex antigens after bone marrow transplantation.
    Hess AD; Fischer AC; Horwitz LR; Bright EC; Hess JM
    Transplant Proc; 1995 Feb; 27(1):1370-3. PubMed ID: 7878915
    [No Abstract]   [Full Text] [Related]  

  • 12. Acceleration of apoptosis in CD4+CD8+ thymocytes by rapamycin accompanied by increased CD4+CD25+ T cells in the periphery.
    Tian L; Lu L; Yuan Z; Lamb JR; Tam PK
    Transplantation; 2004 Jan; 77(2):183-9. PubMed ID: 14742978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of rapamycin on induction of unresponsiveness in ALS-treated, marrow-injected mice.
    Bobbio SA; Wood ML; Monaco AP
    Transplant Proc; 1993 Feb; 25(1 Pt 1):717-8. PubMed ID: 8438453
    [No Abstract]   [Full Text] [Related]  

  • 14. Leflunomide, a novel immunomodulatory agent: in vitro analyses of the mechanism of immunosuppression.
    Chong AS; Gebel H; Finnegan A; Petraitis EE; Jiang XL; Sankary HN; Foster P; Williams JW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):747-9. PubMed ID: 8438466
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of in vivo rapamycin treatment on de novo T-cell development in relation to induction of autoimmune-like immunopathology in the rat.
    Damoiseaux JG; Beijleveld LJ; Schuurman HJ; van Breda Vriesman PJ
    Transplantation; 1996 Oct; 62(7):994-1001. PubMed ID: 8878395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the immunosuppressive macrolides rapamycin and FK 506 in high responder rats presensitized to major histocompatibility complex antigens.
    Propper DJ; Woo J; Macleod AM; Catto GR; Thomson AW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):673-4. PubMed ID: 7679837
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of cyclosporine, rapamycin and FK 506 the survival following allogeneic bone marrow transplantation.
    Markus PM; Cai X; Selvaggi G; Cooper M; Harnaha J; Fung JJ; Starzl TE
    Transplant Proc; 1991 Dec; 23(6):3232-3. PubMed ID: 1721418
    [No Abstract]   [Full Text] [Related]  

  • 18. Demonstration of strong classic immune reactivity after total-body irradiation for bone marrow transplantation. Implications for human T-depleted bone marrow transplantation.
    Gassmann W; von Kolszynski M; Wottge HU; Müller-Ruchholtz W
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2687-8. PubMed ID: 3079091
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of rapamycin on renal microsomal P-450 systems in the rat.
    Yoshimura R; Yoshimura N; Ohyama A; Tsujino T; Kusunose E; Nakatani T; Kahan BD; Stepkowski SM; Kishimoto T
    Transplant Proc; 1993 Feb; 25(1 Pt 1):750-1. PubMed ID: 8438468
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporine-induced syngeneic graft-versus-host disease: recognition of self MHC class II antigens in vivo.
    Hess AD; Horwitz LR; Laulis MK
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1218-21. PubMed ID: 8442094
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.